The company saw a 60 percent increase in revenue during the fourth quarter of 2021 compared to the fourth quarter of 2020.
Implanet saw growth in its spine business, although it noted that activity in the U.S. was heavily affected by COVID-19. U.S. revenue declined 20 percent.
The company said it plans to finalize the globalization of its spine surgery products in 2022 while strengthening its presence in the U.S. and seeking more partnerships.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.